 |
市场调查报告书
商品编码
1454861
消化器官系统的健康市场Digestive Health |
||||||
消化健康和肠道微生物组在各方面的作用是消费者保健领域最热门的话题之一。市场开发商和消费者对 CHC 市场这一令人兴奋的领域越来越感兴趣，消费者已经在该领域建立了需求，并且预计将进一步发展。生物家族的健康益处已被广泛接受并得到越来越多的科学证据的支持，这些证据支持其在越来越广泛的类别中的功效，包括免疫、体重管理、皮肤健康以及心臟、大脑和关节健康。
同时，整个传统的消化疾病类别，如抗酸剂、ORT、泻药和消化?，正在被现代快节奏、压力大的生活方式以及消费者对消化疾病的了解不断增加、有针对性的推出活动和回报所取代。
胃肠道药物预计将成为未来5-10 年内成长最快的CHC 类别之一，预计将成为未来几年成长最快的CHC 类别之一，包括食品不耐受、宿醉疗法等有前景的关键领域和水合健康是发展的关键领域。
本报告详细检视了 10 个主要市场，总结了关键产品销售、品牌表现、最新发展以及到 2033 年的长期预测。
目录
摘要整理
巴西
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 口服补液疗法
- 消化酵素
- 肝臟和胆汁疗法
- 抗惊厥药和肠躁症治疗药
- 其他的肠胃药
- 益生菌
- 展望，预测，机会
中国
- 概要
- 制酸剂
- 泻药
- 止泻
- 口服补液疗法
- 噁心停
- 消化酵素
- 肝臟和胆汁疗法
- 其他的肠胃药
- 益生菌
- 展望，预测，机会
法国
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 噁心停
- 肝臟和胆汁疗法
- 抗惊厥药和肠躁症治疗药
- 其他的肠胃药
- 益生菌
- 展望，预测，机会
德国
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 口服补液疗法
- 噁心停
- 消化酵素
- 肝臟和胆汁疗法
- 抗惊厥药和肠躁症治疗药
- 其他的肠胃药
- 益生菌
- 展望，预测，机会
印度
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 口服补液疗法
- 消化酵素
- 肝臟和胆汁疗法
- 传统的消化疗法
- 益生菌
- 展望，预测，机会
义大利
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 噁心停
- 消化酵素
- 肝臟和胆汁疗法
- 抗惊厥药和肠躁症治疗药
- 益生菌
- 展望，预测，机会
日本
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 噁心停
- 肝臟和胆汁疗法
- 抗惊厥药和肠躁症治疗药
- 传统的消化疗法
- 益生菌
- 展望，预测，机会
墨西哥
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 口服补液疗法
- 噁心停
- 肝臟和胆汁疗法
- 抗惊厥药和肠躁症治疗药
- 其他的肠胃药
- 益生菌
- 展望，预测，机会
英国
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 口服补液疗法
- 噁心停
- 抗惊厥药和肠躁症治疗药
- 益生菌
- 展望，预测，机会
美国
- 概要
- 制酸剂
- 肠胃药
- 泻药
- 止泻
- 口服补液疗法
- 噁心停
- 消化酵素
- 肝臟和胆汁疗法
- 其他的肠胃药
- 益生菌
- 展望，预测，机会
市场概要
- 波兰
- 韩国
- 西班牙
消化器官系统的健康的未来
- 概要
- 定义和NPD
- 扩大的益生菌市场
品牌案例
- doramin
- darukorakkusu
- erekutororitto
- 百事doAC
- tamuzu
预测
Digestive Health and the role of the gut microbiome in multiple facets of health is one of the hottest topics in consumer healthcare. Marketers and consumers are increasingly switched on to this exciting area of the CHC market that already has established demand among consumers and is ripe for further development. With widening acceptance of the health benefits of "the biotics family", the market is primed to expand via new launches across an ever-widening range of categories, including heart, brain and joint health, not to mention immunity, weight management and skin health, backed by a growing body of scientific evidence supporting their efficacy.
Meanwhile, a whole swathe of traditional GIs categories, including antacids, ORTs, laxatives, digestive enzymes & more, are being driven by factors such as modern fast-paced stressful lifestyles, rising consumer understanding of digestive conditions, targeted launch activity and a return to travelling in a post-Covid world.
Forecast to be among the fastest-growing CHC categories in the next 5-10 years, Gastrointestinals is a key arena for future development, including promising key niches such as food intolerance, hangover cures and rehydration wellness.
By examining 10 core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our "Digestive Health" report aims to investigate the untapped potential in this important CHC category.
Key Features of the report:
- An in-depth exploration of the CHC GIs & Probiotics market globally, including Antacids, Laxatives, Antidiarrhoeals, Liver & bile remedies, ORTs, Probiotics and more
- Coverage of 10 major markets from around the world, with topline sales, brand performances, the latest developments, launches and promotional campaigns PLUS mini-profiles of additional markets
- Very latest year-end 2023 sales from the
- just-published DB6, our dedicated CHC sales database, plus historical growth rates back to 2019
- Case studies of key brands, highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
- A dedicated chapter investigates what the future holds for Digestive Health, examining the latest research into the gut-brain axis and new areas of development
- Forecast sales to 2024 & 2025 for all categories and countries, plus longer-term predictions to 2028 & 2033
The report features the latest end-2023 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2028 and 2033.
Diving into the factors affecting the Gastrointestinals & Probiotics markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 10 in-depth country rofiles with insights and predictions, as well as shorter profiles of other key markets.
A dedicated chapter - Digestive Health: What Does the Future Hold? - interrogates likely scenarios for the biotics family (probiotics, prebiotics, synbiotics & postbiotics), including the latest research into the gut-brain axis, the expanding role of gut flora in health and exciting areas of development such as probiotics for mental health, custom probiotics and the gut-muscle axis.
Key questions investigated in this report:
- What are the key differences from market to market in terms of growth drivers, consumer choices and competitive landscape?
- Which marketers and brands stand out and why?
- How will NPD benefit GIs & Probiotics in the years ahead?
- What are the opportunities for e-commerce and digital marketing?
- What new niches and demographics remain underserved?
- What does the future hold for Digestive Health brands?
10 individual markets profiled in depth:
|
|
Categories covered in this report include:
|
|
*sales tracked under VMS in DB6.
Table of Contents
Executive Summary
Brazil
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Oral rehydration treatments
- Digestive enzymes
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
China
- Overview
- Antacids
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
France
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Antinauseants
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
Germany
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
India
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Oral rehydration treatments
- Digestive enzymes
- Liver & bile remedies
- Traditional digestive remedies
- Probiotics
- Outlook, forecast & opportunities
Italy
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Probiotics
- Outlook, forecast & opportunities
Japan
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Antinauseants
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Traditional digestive remedies
- Probiotics
- Outlook, forecast & opportunities
Mexico
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
UK
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Antispasmodics & IBS remedies
- Probiotics
- Outlook, forecast & opportunities
USA
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
Markets in Brief
- Poland
- South Korea
- Spain
The Future of Digestive Health
- Overview
- Definitions & NPD
- The expanding probiotics market
Brand Case Studies
- Dramamine
- Dulcolax
- Electrolit
- Pepcid AC
- Tums
